Skip to main content
. 2021 Sep 18;13(9):1514. doi: 10.3390/pharmaceutics13091514

Table 1.

The eight sets of analyses based on infected patients (model A, B), tested subjects (models F, G, H) and the population (models C, D, E).

Model Cohort 1 Cohort 2
A Hospitalized or fatal infection (U07.1) (Severe) Non-hospitalized COVID-19 (Mild)
B U07.1 cases All other COVID-19 cases
C Hospitalized or fatal infection (U07.1) (Severe) UKBB subjects without COVID-19 Dx or tested-ve
D U07.1 cases UKBB subjects without COVID-19 Dx or tested-ve
E Infected UKBB subjects without COVID-19 Dx or tested-ve
F Infected Tested-ve
G Hospitalized or fatal infection (U07.1) (Severe) Tested-ve
H U07.1 cases Tested-ve

U07.1 is the code for fatal (laboratory-confirmed) COVID-19 infection based on the latest ICD coding. Dx, diagnosis; -ve, negative.